Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines

Canadian Journal of Cardiology

Volumn 32, Issue 8, 2016, Pages 942-948

  Mackie, Andrew S ^a   Liu, Wei ^a   Savu, Anamaria ^a   Marelli, Ariane J ^b   Kaul, Padma ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CANADA; DEFIBRILLATOR; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PACEMAKER; PRACTICE GUIDELINE; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TREND STUDY; ADOLESCENT; AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL HEART PACEMAKER; ENDOCARDITIS; FACTUAL DATABASE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MICROBIOLOGY; MIDDLE AGED; STANDARDS; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; STREPTOCOCCAL INFECTIONS; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AMERICAN HEART ASSOCIATION; ANTIBIOTIC PROPHYLAXIS; CANADA; DATABASES, FACTUAL; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84957895249     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.09.021     Document Type: Article

References (37)

1. 1 Baddour, L.M., Wilson, W.R., Bayer, A.S., et al. Infective endocarditis:diagnosis, antimicrobial therapy, and management of complications. Circulation 111 (2005), e394–434.
2. 2 Murdoch, D.R., Corey, R.G., Hoen, B., et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169 (2009), 463–473.
3. 3 Thuny, F., Grisoli, D., Cautela, J., et al. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol 30 (2014), 1046–1057.
4. 4 Wilson, W., Taubert, K.A., Gewitz, M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation 116 (2007), 1736–1754.
5. 5 Pharis, C.S., Conway, J., Warren, A.E., Bullock, A., MacKie, A.S., The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J 161 (2011), 123–129.
6. 6 Dayer, M.J., Jones, S., Prendergast, B., et al. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet 385 (2015), 1219–1228.
7. 7 Richey, R., Wray, D., Stokes, T., Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ 336 (2008), 770–771.
8. 8 Embil, J.M., Chan, K.L., The American Heart Association 2007 endocarditis prophylaxis guidelines: a compromise between science and common sense. Can J Cardiol 24 (2008), 673–675.
9. 9 Canadian Dental Association. CDA position on prevention of infective endocarditis. Available at: http://www.cda-adc.ca/en/about/position_statements/InfectiveEndocarditis/. Accessed September 11, 2015.
10. 10 Fedeli, U., Schievano, E., Buonfrate, D., Pellizzer, G., Spolaore, P., Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis, 11, 2011, 48.
11. 11 Schneeweiss, S., Robicsek, A., Scranton, R., Zuckerman, D., Solomon, D.H., Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol 60 (2007), 397–409.
12. 12 Levy, R.A., Tamblyn, R., Fitchett, D., McLeod, P., Hanley, J.A., Coding accuracy of hospital discharge for elderly survivors of myocardial infarction. Can J Cardiol 15 (1999), 1277–1282.
13. 13 Austin, P.C., Daly, P.A., Tu, J.V., A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 144 (2002), 290–296.
14. 14 Humphries, K.H., Rankin, J.M., Carere, R.G., et al. Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?. J Clin Epidemiol 53 (2000), 343–349.
15. 15 Rawson, N.S.B., Malcolm, E., Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care data files. Stat Med 14 (1995), 2627–2643.
16. 16 Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
17. 17 Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992), 613–619.
18. 18 D'Hoore, W., Bouckaert, A., Tilquin, C., Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 49 (1996), 1429–1433.
19. 19 Hinkley, D.V., Inference about the change-point in a sequence of random variables. Biometrika 57 (1970), 1–17.
20. 20 Hassan, A., Newman, A.M., Gong, Y., et al. Use of valve surgery in Canada. Can J Cardiol 20 (2004), 149–154.
21. 21 Dunning, J., Gao, H., Chambers, J., et al. Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use—an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg 142 (2011), 776–782.e3.
22. 22 Statistics Canada. Annual demographic estimates: Canada, provinces and territories. Section 2: population by age and sex. Available at: http://www.statcan.gc.ca/pub/91-215-x/2012000/part-partie2-eng.htm. Accessed March 5, 2015.
23. 23 DeSimone, D.C., Tleyjeh, I.M., Correa De Sa, D.D., et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation 126 (2012), 60–64.
24. 24 Pant, S., Patel, N.J., Deshmukh, A., et al. Trends in Infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 65 (2015), 2070–2076.
25. 25 Pasquali, S.K., He, X., Mohamad, Z., et al. Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Am Heart J 163 (2012), 894–899.
26. 26 Rogers, A.M., Schiller, N.B., Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr, 21, 2008, 775.
27. 27 Bor, D.H., Woolhandler, S., Nardin, R., Brusch, J., Himmelstein, D.U., Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One, 8, 2013, e60033.
28. 28 Bikdeli, B., Wang, Y., Kim, N., et al. Trends in hospitalization rates and outcomes of endocarditis among medicare beneficiaries. J Am Coll Cardiol 62 (2013), 2217–2226.
29. 29 Danchin, N., Duval, X., Leport, C., Prophylaxis of infective endocarditis: French recommendations 2002. Heart 91 (2005), 715–718.
30. 30 Duval, X., Delahaye, F., Alla, F., et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 59 (2012), 1968–1976.
31. 31 Day, M.D., Gauvreau, K., Shulman, S., Newburger, J.W., Characteristics of children hospitalized with infective endocarditis. Circulation 119 (2009), 865–870.
32. 32 Sy, R.W., Kritharides, L., Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 31 (2010), 1890–1897.
33. 33 Selton-Suty, C., Célard, M., Le Moing, V., et al. Preeminence of staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54 (2012), 1230–1239.
34. 34 Dzupova, O., Machala, L., Baloun, R., et al. Incidence, predisposing factors, and aetiology of infective endocarditis in the Czech Republic. Scand J Infect Dis 44 (2012), 250–255.
35. 35 Cervera, C., del Rio, A., Garcia, L., et al., Hospital Clinic Endocarditis Study Group. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin 29 (2011), 587–592.
36. 36 Htin, A.K., Friedman, N.D., Hughes, A., et al. Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis—a retrospective cohort study. Intern Med J 43 (2013), 700–705.
37. 37 Partridge, D.G., O'Brien, E., Chapman, A.L.N., Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre. Postgrad Med J 88 (2012), 377–381.